In this week’s video, Dr. Brian G.M. Durie explains how different types of tests for multiple myeloma are used for risk stratification of a patient’s disease.

FISH testing is a standard, widely used technique, but DNA testing will most likely be used more often in the future.

Have a question? Submit it to [email protected]

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to [email protected]

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at [email protected]

Previous Post
FDA Approvals and Prize-Winning Research Are Welcome Good News for Myeloma Patients
Next Post
Future Myeloma Therapy—We Plan, God Laughs

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.